• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of and finding treatments for complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia (FM), long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

New UK Petition: Debate in Parliament the lack of an effective policy for the treatment of M.E.

Jo Best

Senior Member
Debate in Parliament the lack of an effective policy for the treatment of M.E. https://petition.parliament.uk/petitions/200066

Only UK residents or British citizens living abroad may sign petitions posted on the UK Government and Parliament website.

This is a relaunch of a petition created by Ed Lewisohn earlier in 2017, which closed early because of the UK general election. It reached nearly 11,000 signatures in about six weeks, and had support from some MPs. This relaunch is aiming for the 100,000 signatures needed to be considered for a debate in Parliament.

Myalgic Encephalomyelitis (ME) means "muscle pain plus inflammation of the brain/spinal cord", a chronic neurological illness, but "the majority of patients presenting with symptoms of ME in the UK are still referred to psychotherapists for treatment" (Dr Ian Gibson). A policy review is overdue.

More details

The NHS provides psychiatric therapies for what it refers to as "CFS/ME". These therapies are often ineffective and sometimes make patients worse. They are the result of a Myalgic Encephalomyelitis policy heavily influenced by psychiatrists who are skeptical about the existence of Myalgic Encephalomyelitis. It is time for a policy re-think about the effectiveness (and cost-effectiveness) of current treatment.
See: http://www.tymestrust.org (for the effect of current policy on children with ME).

Sign this petition https://petition.parliament.uk/petitions/200066

At 10,000 signatures...
At 10,000 signatures, government will respond to this petition

At 100,000 signatures...
At 100,000 signatures, this petition will be considered for debate in Parliament

Share this petition
  • Created byEdward Lewisohn

  • Deadline13 March 2018All petitions run for 6 months

Jo Best

Senior Member
For ref., this was the petition that closed early because of the general election: https://petition.parliament.uk/archived/petitions/190618

ME (Myalgic Encephalomyelitis) a physical, neurological illness, but remains untreated except with psychotherapy - a failed policy based on the views of discredited psychiatrists who deny that ME exists. A non-psychiatric policy of ME research and treatment would end this ongoing medical scandal.

More details
"Science, Politics, .......and ME: A health scandal in our generation" Dr Ian Gibson (2017, Invest in ME Research)

This was the government's stock response to reaching over 10,000 signatures..

Government responded
The Government accepts the World Health Organisation’s classification of CFS/ME as a neurological condition of unknown origin.

Many potential causes for CFS/ME – including neurological, endocrine, immunological, genetic, psychiatric and infectious – have been investigated, but the variety of symptoms and the range of their severity cannot be fully explained. As the symptoms of CFS/ME resemble those of other forms of debilitating illness and there is no test with which to make an accurate diagnosis, it is not always easy to diagnose single cases of the condition. Diagnosis relies on clinical observation of symptoms by healthcare professionals.

For those affected, it is important that they receive the right diagnosis and that the treatment and support they receive are tailored to their symptoms, needs and circumstances. NHS clinical commissioning groups are responsible for ensuring that local people affected by CFS/ME are able to access appropriate care. To support local services in the diagnosis, treatment and support of patients with CFS/ME, in 2007 the National Institute for Health and Care Excellence (NICE) published a clinical guideline on the management of CFS/ME in adults and children, which sets out best practice on the care, treatment and support of patients with CFS/ME. NICE is the independent expert body responsible for developing robust, evidence based guidance for the NHS to design services that are in line with the best available evidence.

The NICE guideline on CFS/ME recommends treatments, such as cognitive behavioural therapy (CBT) and graded exercise therapy (GET) approaches, that have the clearest research evidence of benefit. However, it does not detract from the right of patients to be involved in decisions about their treatment. The guideline recognises there is no one form of treatment to suit every patient and it does not force patients into treatments they do not want. Instead, it emphasises a collaborative relationship between clinician and patient, that treatment and care should take into account personal needs and preferences, and that healthcare professionals should recognise that the person with CFS/ME is in charge of the aims of the treatment programme. It is also important to clarify that the effectiveness of CBT as a treatment for CFS/ME does not make assumptions about the nature of the illness. CBT is used to help and support people through physical illnesses and is used widely to manage many medical conditions such as arthritis, heart disease and chronic pain.

NICE last reviewed the guidance with its stakeholders, including CFS/ME charities, in 2013. The review found no update was required and at that time no major ongoing studies or research were identified as due to be published in the next three to five years. The full guideline may be viewed on the NICE website at the following link: www.nice.org.uk/guidance/cg53

Recently, NICE has been made aware of three US reports that have indicated there are likely to be changes in diagnostic criteria that could have an impact on the CFS/ME guideline recommendations and decided to start a check of whether the guideline needs updating. NICE has also been made aware of new information about the 2011 PACE trial, which highlighted CBT and GET as safe and effective treatment options for people who have mild or moderate forms of CFS/ME. At the time, NICE concluded that the results of the trial supported its existing guidance, but it will now also consider that new information as part of its check of the guidance. NICE plans to set out its decision regarding an update shortly. More information can be found at the following link:www.nice.org.uk/guidance/cg53

Department of Health

Date closed 3 May 2017
The last time the petition was running I asked the HOC how my Mother who doesn't have an email address could sign the petition - this is part of the reply I received.

Thank you for contacting us.

Providing an e-mail address is an essential requirement when signing a petition. We do allow up to two people to sign a petition using the same email address, so you could use the email of a friend or relative (with their permission, of course). To be able to do this you will have to put the same postcode as the person you are sharing the email with when putting in your details. They would also need to click on the confirmation link sent to them to validate your signature.